Review



tmg cap antibodies  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Santa Cruz Biotechnology tmg cap antibodies
    Tmg Cap Antibodies, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmg+cap+antibodies/2%2C2%2C7-trimethylguanosine+Antibody/pmc06883708-176-103-106
    Average 92 stars, based on 12 article reviews
    tmg cap antibodies - by Bioz Stars, 2026-09
    92/100 stars

    Images

    Related Articles

    Protease Inhibitor:

    Article Title: Trans -splicing of mRNAs links gene transcription to translational control regulated by mTOR
    Article Snippet: .. Reagents were obtained from the following sources: antibodies to phospho-4E-BP1 (Thr37/46) from Cell Signalling (#2855); H3 antibodies from Abcam (#ab1791); anti-rabbit IgG secondary antibodies from KPL (#074–1506); Lambda Protein Phosphatase (Lambda PP) from New England Biolabs (#P0753S); ARTseqTM kit from Epicentre (#RPHMR12126); RNaqueous kit from Ambion (#AM1912); Torin 1 from Tocris (#4247); protease inhibitor cocktail from Sigma-Aldrich (P2714-1BTL); HaltTM Phosphatase Inhibitor Cocktail from Thermo Scientific (#78420); precast gels from BioRad (#4566033 and #4565013); To-Pro-3 iodide from Molecular Probes (#T3605); VECTASHIELD® from Vector Laboratories (#H1000); EdU from Thermo Fisher Catalog (#A10044); Click-iTTM HPG Alexa FluorTM 488 Protein Synthesis Assay Kit from Thermo Fisher (#C10428); TMG-cap antibodies from Santa Cruz (#sc-32,724); Zymo RNA Clean & Concentrator-25 kit (#R1018); Ribo-Zero (#MRZG12324); Clarity Western ECL Substrate from BioRad (#170–5060). ..

    Article Title: Trans-splicing of mRNAs links gene transcription to translational control regulated by mTOR
    Article Snippet: .. Reagents were obtained from the following sources: antibodies to phospho-4E-BP1 (Thr37/46) from Cell Signalling (#2855); H3 antibodies from Abcam (#ab1791); anti-rabbit IgG secondary antibodies from KPL (#074-1506); ARTseqTM kit from Epicentre (#RPHMR12126); RNaqueous kit from Ambion (#AM1912); Torin 1 from Tocris (#4247); protease inhibitor cocktail from Sigma-Aldrich (P2714-1BTL); Halt Phosphatase Inhibitor Cocktail from Thermo Scientific (#78420); precast gels from BioRad (#4566033 and #4565013); To-Pro-3 iodide from Molecular Probes (#T3605); VECTASHIELD ® from Vector Laboratories (#H1000); EdU from Thermo Fisher Catalog (#A10044); Click-iT HPG Alexa Fluor 488 Protein Synthesis Assay Kit from Thermo Fisher (#C10428); TMG-cap antibodies from Santa Cruz (#sc-32724); Zymo RNA Clean & Concentrartor-25 kit (#R1018); Ribo-Zero (#MRZG12324). ..

    Western Blot:

    Article Title: Trans -splicing of mRNAs links gene transcription to translational control regulated by mTOR
    Article Snippet: .. Reagents were obtained from the following sources: antibodies to phospho-4E-BP1 (Thr37/46) from Cell Signalling (#2855); H3 antibodies from Abcam (#ab1791); anti-rabbit IgG secondary antibodies from KPL (#074–1506); Lambda Protein Phosphatase (Lambda PP) from New England Biolabs (#P0753S); ARTseqTM kit from Epicentre (#RPHMR12126); RNaqueous kit from Ambion (#AM1912); Torin 1 from Tocris (#4247); protease inhibitor cocktail from Sigma-Aldrich (P2714-1BTL); HaltTM Phosphatase Inhibitor Cocktail from Thermo Scientific (#78420); precast gels from BioRad (#4566033 and #4565013); To-Pro-3 iodide from Molecular Probes (#T3605); VECTASHIELD® from Vector Laboratories (#H1000); EdU from Thermo Fisher Catalog (#A10044); Click-iTTM HPG Alexa FluorTM 488 Protein Synthesis Assay Kit from Thermo Fisher (#C10428); TMG-cap antibodies from Santa Cruz (#sc-32,724); Zymo RNA Clean & Concentrator-25 kit (#R1018); Ribo-Zero (#MRZG12324); Clarity Western ECL Substrate from BioRad (#170–5060). ..



    Similar Products

    90
    Synaptic Systems tmg cap specific (r1131) polyclonal antibody
    (A) Schematic representation of the experiments. hTR was precipitated from nuclear extracts with an anti-TERT antibody, and purified TERT-hTR complexes were subjected to IP using an <t>anti-TMG</t> <t>cap</t> antibody. (B) hTR associated with TERT eluates from TGS1 M1 and two TGS1 -proficient CTR cells was detected by NB. IgG IP is a CTR for nonspecific binding. EtBr-stained rRNA is a loading CTR. Note that hTR is more abundant in TGS1 mutant cells than in CTR cells. (C) RNA IP with an anti-TMG antibody from TERT-hTR complexes. qRT-PCR on eluates indicates that TERT-associated hTR is not hypermethylated. The monomethylated beta-actin RNA is a negative CTR. Error bars represent standard deviations derived from two independent RNA IP experiements. (D) Top: telomeric repeat amplification protocol (TRAP) performed in 33 dilutions on extracts from cells of the indicated genotypes. IC, internal CTR. TGS1 M1 and M2 cells exhibit higher telomerase activities than both TGS1 -proficient CTR cells and TGS1 M1 rescued cells ( M1R ). Bottom: quantification of TRAP activity. Error bars, SEM. a.u., arbitrary units. (E) Mutations in TGS1 (C1, C2) were generated by CRISPR/Cas9 in the UMUC3 bladder tumor cell line. WB with anti-TGS1 or anti-FLAG antibodies shows reduced levels of endogenous TGS1 in mutant cells and the expression of the TGS1-FLAG rescue construct. See also . (F) qRT-PCR showing that TGS1 CRISPR clones stably expressing FLAG-GFP exhibit increased hTR abundance compared to the same clones stably expressing the rescue construct FLAG-TGS1. Data are from three biological replicates, are normalized to GAPDH and relative to the parental cell line (*p < 0.05; **p < 0.01; one-way ANOVA). (G) TGS1 loss induces telomere lengthening in UMUC3 cells. Telomere restriction fragment (TRF) analysis was performed on genomic DNA extracted from TGS1 mutant (C1, C2) and CTR cell lines kept in culture for the indicated time. PD, population doublings. The growth kinetics were similar for all lines (average doubling time: 1.8 days).
    Tmg Cap Specific (R1131) Polyclonal Antibody, supplied by Synaptic Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmg+cap+antibodies/tmg+cap+specific++r1131++polyclonal+antibody/pmc07156301-4-0-7
    Average 90 stars, based on 1 article reviews
    tmg cap specific (r1131) polyclonal antibody - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Synaptic Systems anti-tmg cap specific antibody r1131
    (A) Schematic representation of the experiments. hTR was precipitated from nuclear extracts with an anti-TERT antibody, and purified TERT-hTR complexes were subjected to IP using an <t>anti-TMG</t> <t>cap</t> antibody. (B) hTR associated with TERT eluates from TGS1 M1 and two TGS1 -proficient CTR cells was detected by NB. IgG IP is a CTR for nonspecific binding. EtBr-stained rRNA is a loading CTR. Note that hTR is more abundant in TGS1 mutant cells than in CTR cells. (C) RNA IP with an anti-TMG antibody from TERT-hTR complexes. qRT-PCR on eluates indicates that TERT-associated hTR is not hypermethylated. The monomethylated beta-actin RNA is a negative CTR. Error bars represent standard deviations derived from two independent RNA IP experiements. (D) Top: telomeric repeat amplification protocol (TRAP) performed in 33 dilutions on extracts from cells of the indicated genotypes. IC, internal CTR. TGS1 M1 and M2 cells exhibit higher telomerase activities than both TGS1 -proficient CTR cells and TGS1 M1 rescued cells ( M1R ). Bottom: quantification of TRAP activity. Error bars, SEM. a.u., arbitrary units. (E) Mutations in TGS1 (C1, C2) were generated by CRISPR/Cas9 in the UMUC3 bladder tumor cell line. WB with anti-TGS1 or anti-FLAG antibodies shows reduced levels of endogenous TGS1 in mutant cells and the expression of the TGS1-FLAG rescue construct. See also . (F) qRT-PCR showing that TGS1 CRISPR clones stably expressing FLAG-GFP exhibit increased hTR abundance compared to the same clones stably expressing the rescue construct FLAG-TGS1. Data are from three biological replicates, are normalized to GAPDH and relative to the parental cell line (*p < 0.05; **p < 0.01; one-way ANOVA). (G) TGS1 loss induces telomere lengthening in UMUC3 cells. Telomere restriction fragment (TRF) analysis was performed on genomic DNA extracted from TGS1 mutant (C1, C2) and CTR cell lines kept in culture for the indicated time. PD, population doublings. The growth kinetics were similar for all lines (average doubling time: 1.8 days).
    Anti Tmg Cap Specific Antibody R1131, supplied by Synaptic Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmg+cap+antibodies/tmg+cap+specific++r1131++polyclonal+antibody/pmc07156301-328-9-16
    Average 90 stars, based on 1 article reviews
    anti-tmg cap specific antibody r1131 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    92
    Santa Cruz Biotechnology tmg cap antibodies
    (A) Schematic representation of the experiments. hTR was precipitated from nuclear extracts with an anti-TERT antibody, and purified TERT-hTR complexes were subjected to IP using an <t>anti-TMG</t> <t>cap</t> antibody. (B) hTR associated with TERT eluates from TGS1 M1 and two TGS1 -proficient CTR cells was detected by NB. IgG IP is a CTR for nonspecific binding. EtBr-stained rRNA is a loading CTR. Note that hTR is more abundant in TGS1 mutant cells than in CTR cells. (C) RNA IP with an anti-TMG antibody from TERT-hTR complexes. qRT-PCR on eluates indicates that TERT-associated hTR is not hypermethylated. The monomethylated beta-actin RNA is a negative CTR. Error bars represent standard deviations derived from two independent RNA IP experiements. (D) Top: telomeric repeat amplification protocol (TRAP) performed in 33 dilutions on extracts from cells of the indicated genotypes. IC, internal CTR. TGS1 M1 and M2 cells exhibit higher telomerase activities than both TGS1 -proficient CTR cells and TGS1 M1 rescued cells ( M1R ). Bottom: quantification of TRAP activity. Error bars, SEM. a.u., arbitrary units. (E) Mutations in TGS1 (C1, C2) were generated by CRISPR/Cas9 in the UMUC3 bladder tumor cell line. WB with anti-TGS1 or anti-FLAG antibodies shows reduced levels of endogenous TGS1 in mutant cells and the expression of the TGS1-FLAG rescue construct. See also . (F) qRT-PCR showing that TGS1 CRISPR clones stably expressing FLAG-GFP exhibit increased hTR abundance compared to the same clones stably expressing the rescue construct FLAG-TGS1. Data are from three biological replicates, are normalized to GAPDH and relative to the parental cell line (*p < 0.05; **p < 0.01; one-way ANOVA). (G) TGS1 loss induces telomere lengthening in UMUC3 cells. Telomere restriction fragment (TRF) analysis was performed on genomic DNA extracted from TGS1 mutant (C1, C2) and CTR cell lines kept in culture for the indicated time. PD, population doublings. The growth kinetics were similar for all lines (average doubling time: 1.8 days).
    Tmg Cap Antibodies, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmg+cap+antibodies/2%2C2%2C7-trimethylguanosine+Antibody/pmc06883708-176-103-106
    Average 92 stars, based on 1 article reviews
    tmg cap antibodies - by Bioz Stars, 2026-09
    92/100 stars
      Buy from Supplier

    90
    Millipore agarose beads coupled to antibodies against the characteristic tri-methyl guanosine cap of snrnas (tmg beads)
    SNRPN exhibits similar behaviour to SNRPB in SH-SY5Y cells. (A) SH-SY5Y cells transiently expressing YFP–SNRPN and fixed after 24, 48 and 72 h show variations in distribution of the YFP–SNRPN with time. Immunostaining with Y12 (detecting Sm proteins, red on overlay) and anti-coilin (white on overlay) shows splicing speckles (chevron arrowheads) and cajal bodies (CBs, triangular arrowheads) respectively. Images are deconvolved z -stacks with 0.2 µm spacing. (B) After transient expression, SNRPN initially localises diffusely in the cytoplasm, before localising to speckles at the 48 and 72 h time-points. Results are mean±s.d. from three independent experiments, n =100 cells per experiment. (C) Western blot analysis of snRNPs immunoprecipitated using TMG beads (against the characteristic tri-methyl guanosine Cap of <t>snRNAs,</t> left hand lane) confirms that both YFP–SNRPN (detected with anti-YFP, top row) and mCherry–SNRPN (detected with anti-mCherry, bottom row) are incorporated into snRNPs. (D) mCherry–SNRPN cytoplasmic structures are mobile and stain with the lipophilic dye BODIPY 493. Chevron arrowheads identify mCherry–SNRPN structures stained with BODIPY 493; triangular arrowheads identify BODIPY 493-stained vesicles not containing mCherry–SNRPN. mCherry alone does not accumulate in BODIPY 493-stained vesicles. Cells were imaged approximately every 4 s for 9 min. Images are single deconvolved z -sections. (E) mCherry–SNRPN and GFP–SMN colocalise in cytoplasmic foci in SH-SY5Y cells (chevron arrowheads in left hand panels), whereas YFP alone shows no accumulation in mCherry-SNRPN foci (triangular arrowheads in right hand panels). White signal on the overlay indicates areas of colocalisation. Images are single deconvolved z -sections. (F) Comparison of the percentage of mCherry–SNRPN vesicles per cell colocalising with GFP–SMN to those showing co-incidental overlap with YFP alone confirms the colocalisation. Results are mean±s.d., n =5 ( P <0.0001, unpaired two-tailed t -test). Scale bars: 7 µm.
    Agarose Beads Coupled To Antibodies Against The Characteristic Tri Methyl Guanosine Cap Of Snrnas (Tmg Beads), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmg+cap+antibodies/agarose+beads+coupled+to+antibodies+against+the+characteristic+tri+methyl+guanosine+cap+of+snrnas++tmg+beads+/pmc05963842-186-47-50
    Average 90 stars, based on 1 article reviews
    agarose beads coupled to antibodies against the characteristic tri-methyl guanosine cap of snrnas (tmg beads) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Millipore antibodies to tmg-cap na02
    SNRPN exhibits similar behaviour to SNRPB in SH-SY5Y cells. (A) SH-SY5Y cells transiently expressing YFP–SNRPN and fixed after 24, 48 and 72 h show variations in distribution of the YFP–SNRPN with time. Immunostaining with Y12 (detecting Sm proteins, red on overlay) and anti-coilin (white on overlay) shows splicing speckles (chevron arrowheads) and cajal bodies (CBs, triangular arrowheads) respectively. Images are deconvolved z -stacks with 0.2 µm spacing. (B) After transient expression, SNRPN initially localises diffusely in the cytoplasm, before localising to speckles at the 48 and 72 h time-points. Results are mean±s.d. from three independent experiments, n =100 cells per experiment. (C) Western blot analysis of snRNPs immunoprecipitated using TMG beads (against the characteristic tri-methyl guanosine Cap of <t>snRNAs,</t> left hand lane) confirms that both YFP–SNRPN (detected with anti-YFP, top row) and mCherry–SNRPN (detected with anti-mCherry, bottom row) are incorporated into snRNPs. (D) mCherry–SNRPN cytoplasmic structures are mobile and stain with the lipophilic dye BODIPY 493. Chevron arrowheads identify mCherry–SNRPN structures stained with BODIPY 493; triangular arrowheads identify BODIPY 493-stained vesicles not containing mCherry–SNRPN. mCherry alone does not accumulate in BODIPY 493-stained vesicles. Cells were imaged approximately every 4 s for 9 min. Images are single deconvolved z -sections. (E) mCherry–SNRPN and GFP–SMN colocalise in cytoplasmic foci in SH-SY5Y cells (chevron arrowheads in left hand panels), whereas YFP alone shows no accumulation in mCherry-SNRPN foci (triangular arrowheads in right hand panels). White signal on the overlay indicates areas of colocalisation. Images are single deconvolved z -sections. (F) Comparison of the percentage of mCherry–SNRPN vesicles per cell colocalising with GFP–SMN to those showing co-incidental overlap with YFP alone confirms the colocalisation. Results are mean±s.d., n =5 ( P <0.0001, unpaired two-tailed t -test). Scale bars: 7 µm.
    Antibodies To Tmg Cap Na02, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmg+cap+antibodies/anti+tmg+antibody/pm25788273-143-56-61
    Average 90 stars, based on 1 article reviews
    antibodies to tmg-cap na02 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Oncogene Science Inc mouse mab k121 against the trimethylguanosine (tmg) cap on snrnas antibody
    SNRPN exhibits similar behaviour to SNRPB in SH-SY5Y cells. (A) SH-SY5Y cells transiently expressing YFP–SNRPN and fixed after 24, 48 and 72 h show variations in distribution of the YFP–SNRPN with time. Immunostaining with Y12 (detecting Sm proteins, red on overlay) and anti-coilin (white on overlay) shows splicing speckles (chevron arrowheads) and cajal bodies (CBs, triangular arrowheads) respectively. Images are deconvolved z -stacks with 0.2 µm spacing. (B) After transient expression, SNRPN initially localises diffusely in the cytoplasm, before localising to speckles at the 48 and 72 h time-points. Results are mean±s.d. from three independent experiments, n =100 cells per experiment. (C) Western blot analysis of snRNPs immunoprecipitated using TMG beads (against the characteristic tri-methyl guanosine Cap of <t>snRNAs,</t> left hand lane) confirms that both YFP–SNRPN (detected with anti-YFP, top row) and mCherry–SNRPN (detected with anti-mCherry, bottom row) are incorporated into snRNPs. (D) mCherry–SNRPN cytoplasmic structures are mobile and stain with the lipophilic dye BODIPY 493. Chevron arrowheads identify mCherry–SNRPN structures stained with BODIPY 493; triangular arrowheads identify BODIPY 493-stained vesicles not containing mCherry–SNRPN. mCherry alone does not accumulate in BODIPY 493-stained vesicles. Cells were imaged approximately every 4 s for 9 min. Images are single deconvolved z -sections. (E) mCherry–SNRPN and GFP–SMN colocalise in cytoplasmic foci in SH-SY5Y cells (chevron arrowheads in left hand panels), whereas YFP alone shows no accumulation in mCherry-SNRPN foci (triangular arrowheads in right hand panels). White signal on the overlay indicates areas of colocalisation. Images are single deconvolved z -sections. (F) Comparison of the percentage of mCherry–SNRPN vesicles per cell colocalising with GFP–SMN to those showing co-incidental overlap with YFP alone confirms the colocalisation. Results are mean±s.d., n =5 ( P <0.0001, unpaired two-tailed t -test). Scale bars: 7 µm.
    Mouse Mab K121 Against The Trimethylguanosine (Tmg) Cap On Snrnas Antibody, supplied by Oncogene Science Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmg+cap+antibodies/mouse+mab+k121+against+the+trimethylguanosine++tmg++cap+on+snrnas+antibody/pmc03566365-57-138-139
    Average 90 stars, based on 1 article reviews
    mouse mab k121 against the trimethylguanosine (tmg) cap on snrnas antibody - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Millipore mouse monoclonal antibodies anti-2,2,7-trimethylguanosine cap (tmg-cap) spliceosomal snrnps
    SNRPN exhibits similar behaviour to SNRPB in SH-SY5Y cells. (A) SH-SY5Y cells transiently expressing YFP–SNRPN and fixed after 24, 48 and 72 h show variations in distribution of the YFP–SNRPN with time. Immunostaining with Y12 (detecting Sm proteins, red on overlay) and anti-coilin (white on overlay) shows splicing speckles (chevron arrowheads) and cajal bodies (CBs, triangular arrowheads) respectively. Images are deconvolved z -stacks with 0.2 µm spacing. (B) After transient expression, SNRPN initially localises diffusely in the cytoplasm, before localising to speckles at the 48 and 72 h time-points. Results are mean±s.d. from three independent experiments, n =100 cells per experiment. (C) Western blot analysis of snRNPs immunoprecipitated using TMG beads (against the characteristic tri-methyl guanosine Cap of <t>snRNAs,</t> left hand lane) confirms that both YFP–SNRPN (detected with anti-YFP, top row) and mCherry–SNRPN (detected with anti-mCherry, bottom row) are incorporated into snRNPs. (D) mCherry–SNRPN cytoplasmic structures are mobile and stain with the lipophilic dye BODIPY 493. Chevron arrowheads identify mCherry–SNRPN structures stained with BODIPY 493; triangular arrowheads identify BODIPY 493-stained vesicles not containing mCherry–SNRPN. mCherry alone does not accumulate in BODIPY 493-stained vesicles. Cells were imaged approximately every 4 s for 9 min. Images are single deconvolved z -sections. (E) mCherry–SNRPN and GFP–SMN colocalise in cytoplasmic foci in SH-SY5Y cells (chevron arrowheads in left hand panels), whereas YFP alone shows no accumulation in mCherry-SNRPN foci (triangular arrowheads in right hand panels). White signal on the overlay indicates areas of colocalisation. Images are single deconvolved z -sections. (F) Comparison of the percentage of mCherry–SNRPN vesicles per cell colocalising with GFP–SMN to those showing co-incidental overlap with YFP alone confirms the colocalisation. Results are mean±s.d., n =5 ( P <0.0001, unpaired two-tailed t -test). Scale bars: 7 µm.
    Mouse Monoclonal Antibodies Anti 2,2,7 Trimethylguanosine Cap (Tmg Cap) Spliceosomal Snrnps, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmg+cap+antibodies/anti+2++3++cyclic+nucleotide+3++phosphodiesterase/pm22249111-64-36-38
    Average 90 stars, based on 1 article reviews
    mouse monoclonal antibodies anti-2,2,7-trimethylguanosine cap (tmg-cap) spliceosomal snrnps - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Millipore anti-tmg-cap antibody
    SNRPN exhibits similar behaviour to SNRPB in SH-SY5Y cells. (A) SH-SY5Y cells transiently expressing YFP–SNRPN and fixed after 24, 48 and 72 h show variations in distribution of the YFP–SNRPN with time. Immunostaining with Y12 (detecting Sm proteins, red on overlay) and anti-coilin (white on overlay) shows splicing speckles (chevron arrowheads) and cajal bodies (CBs, triangular arrowheads) respectively. Images are deconvolved z -stacks with 0.2 µm spacing. (B) After transient expression, SNRPN initially localises diffusely in the cytoplasm, before localising to speckles at the 48 and 72 h time-points. Results are mean±s.d. from three independent experiments, n =100 cells per experiment. (C) Western blot analysis of snRNPs immunoprecipitated using TMG beads (against the characteristic tri-methyl guanosine Cap of <t>snRNAs,</t> left hand lane) confirms that both YFP–SNRPN (detected with anti-YFP, top row) and mCherry–SNRPN (detected with anti-mCherry, bottom row) are incorporated into snRNPs. (D) mCherry–SNRPN cytoplasmic structures are mobile and stain with the lipophilic dye BODIPY 493. Chevron arrowheads identify mCherry–SNRPN structures stained with BODIPY 493; triangular arrowheads identify BODIPY 493-stained vesicles not containing mCherry–SNRPN. mCherry alone does not accumulate in BODIPY 493-stained vesicles. Cells were imaged approximately every 4 s for 9 min. Images are single deconvolved z -sections. (E) mCherry–SNRPN and GFP–SMN colocalise in cytoplasmic foci in SH-SY5Y cells (chevron arrowheads in left hand panels), whereas YFP alone shows no accumulation in mCherry-SNRPN foci (triangular arrowheads in right hand panels). White signal on the overlay indicates areas of colocalisation. Images are single deconvolved z -sections. (F) Comparison of the percentage of mCherry–SNRPN vesicles per cell colocalising with GFP–SMN to those showing co-incidental overlap with YFP alone confirms the colocalisation. Results are mean±s.d., n =5 ( P <0.0001, unpaired two-tailed t -test). Scale bars: 7 µm.
    Anti Tmg Cap Antibody, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmg+cap+antibodies/anti+tmg+antibody/pmc03365748-181-10-13
    Average 90 stars, based on 1 article reviews
    anti-tmg-cap antibody - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A) Schematic representation of the experiments. hTR was precipitated from nuclear extracts with an anti-TERT antibody, and purified TERT-hTR complexes were subjected to IP using an anti-TMG cap antibody. (B) hTR associated with TERT eluates from TGS1 M1 and two TGS1 -proficient CTR cells was detected by NB. IgG IP is a CTR for nonspecific binding. EtBr-stained rRNA is a loading CTR. Note that hTR is more abundant in TGS1 mutant cells than in CTR cells. (C) RNA IP with an anti-TMG antibody from TERT-hTR complexes. qRT-PCR on eluates indicates that TERT-associated hTR is not hypermethylated. The monomethylated beta-actin RNA is a negative CTR. Error bars represent standard deviations derived from two independent RNA IP experiements. (D) Top: telomeric repeat amplification protocol (TRAP) performed in 33 dilutions on extracts from cells of the indicated genotypes. IC, internal CTR. TGS1 M1 and M2 cells exhibit higher telomerase activities than both TGS1 -proficient CTR cells and TGS1 M1 rescued cells ( M1R ). Bottom: quantification of TRAP activity. Error bars, SEM. a.u., arbitrary units. (E) Mutations in TGS1 (C1, C2) were generated by CRISPR/Cas9 in the UMUC3 bladder tumor cell line. WB with anti-TGS1 or anti-FLAG antibodies shows reduced levels of endogenous TGS1 in mutant cells and the expression of the TGS1-FLAG rescue construct. See also . (F) qRT-PCR showing that TGS1 CRISPR clones stably expressing FLAG-GFP exhibit increased hTR abundance compared to the same clones stably expressing the rescue construct FLAG-TGS1. Data are from three biological replicates, are normalized to GAPDH and relative to the parental cell line (*p < 0.05; **p < 0.01; one-way ANOVA). (G) TGS1 loss induces telomere lengthening in UMUC3 cells. Telomere restriction fragment (TRF) analysis was performed on genomic DNA extracted from TGS1 mutant (C1, C2) and CTR cell lines kept in culture for the indicated time. PD, population doublings. The growth kinetics were similar for all lines (average doubling time: 1.8 days).

    Journal: Cell reports

    Article Title: Loss of Human TGS1 Hypermethylase Promotes Increased Telomerase RNA and Telomere Elongation

    doi: 10.1016/j.celrep.2020.01.004

    Figure Lengend Snippet: (A) Schematic representation of the experiments. hTR was precipitated from nuclear extracts with an anti-TERT antibody, and purified TERT-hTR complexes were subjected to IP using an anti-TMG cap antibody. (B) hTR associated with TERT eluates from TGS1 M1 and two TGS1 -proficient CTR cells was detected by NB. IgG IP is a CTR for nonspecific binding. EtBr-stained rRNA is a loading CTR. Note that hTR is more abundant in TGS1 mutant cells than in CTR cells. (C) RNA IP with an anti-TMG antibody from TERT-hTR complexes. qRT-PCR on eluates indicates that TERT-associated hTR is not hypermethylated. The monomethylated beta-actin RNA is a negative CTR. Error bars represent standard deviations derived from two independent RNA IP experiements. (D) Top: telomeric repeat amplification protocol (TRAP) performed in 33 dilutions on extracts from cells of the indicated genotypes. IC, internal CTR. TGS1 M1 and M2 cells exhibit higher telomerase activities than both TGS1 -proficient CTR cells and TGS1 M1 rescued cells ( M1R ). Bottom: quantification of TRAP activity. Error bars, SEM. a.u., arbitrary units. (E) Mutations in TGS1 (C1, C2) were generated by CRISPR/Cas9 in the UMUC3 bladder tumor cell line. WB with anti-TGS1 or anti-FLAG antibodies shows reduced levels of endogenous TGS1 in mutant cells and the expression of the TGS1-FLAG rescue construct. See also . (F) qRT-PCR showing that TGS1 CRISPR clones stably expressing FLAG-GFP exhibit increased hTR abundance compared to the same clones stably expressing the rescue construct FLAG-TGS1. Data are from three biological replicates, are normalized to GAPDH and relative to the parental cell line (*p < 0.05; **p < 0.01; one-way ANOVA). (G) TGS1 loss induces telomere lengthening in UMUC3 cells. Telomere restriction fragment (TRF) analysis was performed on genomic DNA extracted from TGS1 mutant (C1, C2) and CTR cell lines kept in culture for the indicated time. PD, population doublings. The growth kinetics were similar for all lines (average doubling time: 1.8 days).

    Article Snippet: TMG cap specific (R1131) polyclonal antibody , Synaptic Systems , Cat# 201 002.

    Techniques: Purification, Binding Assay, Staining, Mutagenesis, Quantitative RT-PCR, Derivative Assay, Amplification, Activity Assay, Generated, CRISPR, Expressing, Construct, Clone Assay, Stable Transfection

    KEY RESOURCES TABLE

    Journal: Cell reports

    Article Title: Loss of Human TGS1 Hypermethylase Promotes Increased Telomerase RNA and Telomere Elongation

    doi: 10.1016/j.celrep.2020.01.004

    Figure Lengend Snippet: KEY RESOURCES TABLE

    Article Snippet: TMG cap specific (R1131) polyclonal antibody , Synaptic Systems , Cat# 201 002.

    Techniques: Recombinant, Sequencing, CRISPR, Labeling, Software, Control

    (A) Schematic representation of the experiments. hTR was precipitated from nuclear extracts with an anti-TERT antibody, and purified TERT-hTR complexes were subjected to IP using an anti-TMG cap antibody. (B) hTR associated with TERT eluates from TGS1 M1 and two TGS1 -proficient CTR cells was detected by NB. IgG IP is a CTR for nonspecific binding. EtBr-stained rRNA is a loading CTR. Note that hTR is more abundant in TGS1 mutant cells than in CTR cells. (C) RNA IP with an anti-TMG antibody from TERT-hTR complexes. qRT-PCR on eluates indicates that TERT-associated hTR is not hypermethylated. The monomethylated beta-actin RNA is a negative CTR. Error bars represent standard deviations derived from two independent RNA IP experiements. (D) Top: telomeric repeat amplification protocol (TRAP) performed in 33 dilutions on extracts from cells of the indicated genotypes. IC, internal CTR. TGS1 M1 and M2 cells exhibit higher telomerase activities than both TGS1 -proficient CTR cells and TGS1 M1 rescued cells ( M1R ). Bottom: quantification of TRAP activity. Error bars, SEM. a.u., arbitrary units. (E) Mutations in TGS1 (C1, C2) were generated by CRISPR/Cas9 in the UMUC3 bladder tumor cell line. WB with anti-TGS1 or anti-FLAG antibodies shows reduced levels of endogenous TGS1 in mutant cells and the expression of the TGS1-FLAG rescue construct. See also . (F) qRT-PCR showing that TGS1 CRISPR clones stably expressing FLAG-GFP exhibit increased hTR abundance compared to the same clones stably expressing the rescue construct FLAG-TGS1. Data are from three biological replicates, are normalized to GAPDH and relative to the parental cell line (*p < 0.05; **p < 0.01; one-way ANOVA). (G) TGS1 loss induces telomere lengthening in UMUC3 cells. Telomere restriction fragment (TRF) analysis was performed on genomic DNA extracted from TGS1 mutant (C1, C2) and CTR cell lines kept in culture for the indicated time. PD, population doublings. The growth kinetics were similar for all lines (average doubling time: 1.8 days).

    Journal: Cell reports

    Article Title: Loss of Human TGS1 Hypermethylase Promotes Increased Telomerase RNA and Telomere Elongation

    doi: 10.1016/j.celrep.2020.01.004

    Figure Lengend Snippet: (A) Schematic representation of the experiments. hTR was precipitated from nuclear extracts with an anti-TERT antibody, and purified TERT-hTR complexes were subjected to IP using an anti-TMG cap antibody. (B) hTR associated with TERT eluates from TGS1 M1 and two TGS1 -proficient CTR cells was detected by NB. IgG IP is a CTR for nonspecific binding. EtBr-stained rRNA is a loading CTR. Note that hTR is more abundant in TGS1 mutant cells than in CTR cells. (C) RNA IP with an anti-TMG antibody from TERT-hTR complexes. qRT-PCR on eluates indicates that TERT-associated hTR is not hypermethylated. The monomethylated beta-actin RNA is a negative CTR. Error bars represent standard deviations derived from two independent RNA IP experiements. (D) Top: telomeric repeat amplification protocol (TRAP) performed in 33 dilutions on extracts from cells of the indicated genotypes. IC, internal CTR. TGS1 M1 and M2 cells exhibit higher telomerase activities than both TGS1 -proficient CTR cells and TGS1 M1 rescued cells ( M1R ). Bottom: quantification of TRAP activity. Error bars, SEM. a.u., arbitrary units. (E) Mutations in TGS1 (C1, C2) were generated by CRISPR/Cas9 in the UMUC3 bladder tumor cell line. WB with anti-TGS1 or anti-FLAG antibodies shows reduced levels of endogenous TGS1 in mutant cells and the expression of the TGS1-FLAG rescue construct. See also . (F) qRT-PCR showing that TGS1 CRISPR clones stably expressing FLAG-GFP exhibit increased hTR abundance compared to the same clones stably expressing the rescue construct FLAG-TGS1. Data are from three biological replicates, are normalized to GAPDH and relative to the parental cell line (*p < 0.05; **p < 0.01; one-way ANOVA). (G) TGS1 loss induces telomere lengthening in UMUC3 cells. Telomere restriction fragment (TRF) analysis was performed on genomic DNA extracted from TGS1 mutant (C1, C2) and CTR cell lines kept in culture for the indicated time. PD, population doublings. The growth kinetics were similar for all lines (average doubling time: 1.8 days).

    Article Snippet: Purified RNA was then subjected to IP with the R1131 anti-TMG cap specific antibody ( ) (Synaptic Systems).

    Techniques: Purification, Binding Assay, Staining, Mutagenesis, Quantitative RT-PCR, Derivative Assay, Amplification, Activity Assay, Generated, CRISPR, Expressing, Construct, Clone Assay, Stable Transfection

    SNRPN exhibits similar behaviour to SNRPB in SH-SY5Y cells. (A) SH-SY5Y cells transiently expressing YFP–SNRPN and fixed after 24, 48 and 72 h show variations in distribution of the YFP–SNRPN with time. Immunostaining with Y12 (detecting Sm proteins, red on overlay) and anti-coilin (white on overlay) shows splicing speckles (chevron arrowheads) and cajal bodies (CBs, triangular arrowheads) respectively. Images are deconvolved z -stacks with 0.2 µm spacing. (B) After transient expression, SNRPN initially localises diffusely in the cytoplasm, before localising to speckles at the 48 and 72 h time-points. Results are mean±s.d. from three independent experiments, n =100 cells per experiment. (C) Western blot analysis of snRNPs immunoprecipitated using TMG beads (against the characteristic tri-methyl guanosine Cap of snRNAs, left hand lane) confirms that both YFP–SNRPN (detected with anti-YFP, top row) and mCherry–SNRPN (detected with anti-mCherry, bottom row) are incorporated into snRNPs. (D) mCherry–SNRPN cytoplasmic structures are mobile and stain with the lipophilic dye BODIPY 493. Chevron arrowheads identify mCherry–SNRPN structures stained with BODIPY 493; triangular arrowheads identify BODIPY 493-stained vesicles not containing mCherry–SNRPN. mCherry alone does not accumulate in BODIPY 493-stained vesicles. Cells were imaged approximately every 4 s for 9 min. Images are single deconvolved z -sections. (E) mCherry–SNRPN and GFP–SMN colocalise in cytoplasmic foci in SH-SY5Y cells (chevron arrowheads in left hand panels), whereas YFP alone shows no accumulation in mCherry-SNRPN foci (triangular arrowheads in right hand panels). White signal on the overlay indicates areas of colocalisation. Images are single deconvolved z -sections. (F) Comparison of the percentage of mCherry–SNRPN vesicles per cell colocalising with GFP–SMN to those showing co-incidental overlap with YFP alone confirms the colocalisation. Results are mean±s.d., n =5 ( P <0.0001, unpaired two-tailed t -test). Scale bars: 7 µm.

    Journal: Journal of Cell Science

    Article Title: Neurochondrin interacts with the SMN protein suggesting a novel mechanism for spinal muscular atrophy pathology

    doi: 10.1242/jcs.211482

    Figure Lengend Snippet: SNRPN exhibits similar behaviour to SNRPB in SH-SY5Y cells. (A) SH-SY5Y cells transiently expressing YFP–SNRPN and fixed after 24, 48 and 72 h show variations in distribution of the YFP–SNRPN with time. Immunostaining with Y12 (detecting Sm proteins, red on overlay) and anti-coilin (white on overlay) shows splicing speckles (chevron arrowheads) and cajal bodies (CBs, triangular arrowheads) respectively. Images are deconvolved z -stacks with 0.2 µm spacing. (B) After transient expression, SNRPN initially localises diffusely in the cytoplasm, before localising to speckles at the 48 and 72 h time-points. Results are mean±s.d. from three independent experiments, n =100 cells per experiment. (C) Western blot analysis of snRNPs immunoprecipitated using TMG beads (against the characteristic tri-methyl guanosine Cap of snRNAs, left hand lane) confirms that both YFP–SNRPN (detected with anti-YFP, top row) and mCherry–SNRPN (detected with anti-mCherry, bottom row) are incorporated into snRNPs. (D) mCherry–SNRPN cytoplasmic structures are mobile and stain with the lipophilic dye BODIPY 493. Chevron arrowheads identify mCherry–SNRPN structures stained with BODIPY 493; triangular arrowheads identify BODIPY 493-stained vesicles not containing mCherry–SNRPN. mCherry alone does not accumulate in BODIPY 493-stained vesicles. Cells were imaged approximately every 4 s for 9 min. Images are single deconvolved z -sections. (E) mCherry–SNRPN and GFP–SMN colocalise in cytoplasmic foci in SH-SY5Y cells (chevron arrowheads in left hand panels), whereas YFP alone shows no accumulation in mCherry-SNRPN foci (triangular arrowheads in right hand panels). White signal on the overlay indicates areas of colocalisation. Images are single deconvolved z -sections. (F) Comparison of the percentage of mCherry–SNRPN vesicles per cell colocalising with GFP–SMN to those showing co-incidental overlap with YFP alone confirms the colocalisation. Results are mean±s.d., n =5 ( P <0.0001, unpaired two-tailed t -test). Scale bars: 7 µm.

    Article Snippet: To investigate whether the interaction between NCDN and SMN could reflect a previously unidentified role for NCDN in snRNP assembly, splicing snRNPs were affinity purified from whole-cell lysates of SH-SY5Y cells constitutively expressing NCDN–GFP using agarose beads coupled to antibodies against the characteristic tri-methyl guanosine Cap of snRNAs (TMG beads, Millipore) ( A).

    Techniques: Expressing, Immunostaining, Western Blot, Immunoprecipitation, Staining, Comparison, Two Tailed Test

    NCDN does not co-purify with snRNPs, while NCDN and SMN interact with Rab5 and colocalise with a subset of Rab5 vesicles within neurites of SH-SY5Y cells. (A) Incubation of whole-cell lysate from an SH-SY5Y cell line constitutively expressing NCDN–GFP with agarose beads conjugated to antibodies against the tri-methyl guanosine cap (Me3Gppp) of snRNAs (TMG beads) affinity purifies snRNPs as evidenced by the enrichment of the core snRNP protein SNRPN (detected with anti-SNRPN antibody, bottom row). The enriched snRNP fraction also contains SMN, which is essential for snRNP assembly. NCDN–GFP, however, does not co-enrich with snRNPs. Also shown is the core structure of mature snRNPs consisting of the heptameric Sm protein ring bound at the Sm-binding site of snRNA, as well as the characteristic tri-methyl guanosine Cap of snRNAs (Me 3 Gppp) at the 5′ end. (B) Affinity isolation of mRFP–Rab5 using RFP-Trap from cells co-transfected with plasmids to express mRFP–Rab5 together with NCDN–GFP, GFP–SMN or YFP alone co-enriches both NCDN–GFP (top row, detected with anti-GFP antibody, band is present in RFP-Trap lane but not Sepharose beads lane) and SMN-GFP (second row, detected with anti-GFP antibody, band is present in RFP-Trap lane but not Sepharose beads lane), but not YFP (third row, no band detected in RFP-Trap lane). Endogenous SMN (fourth row, detected with mouse anti-SMN) co-enriches with mRFP–Rab5 in all three samples. Detection of mRFP–Rab5 (bottom row, detected with anti-RFP antibody) confirms substantial enrichment of mRFP–Rab5 in all three samples. (C) Both GFP–SMN and NCDN–GFP partially colocalise with mRFP–Rab5 in a subset of mRFP–Rab5-containing vesicles in co-transfected SH-SY5Y cells (white signal in overlaid images, top row; yellow signal in colocalisation images, bottom row). (D) Enlargement of the boxed areas in C confirms that the colocalisation between SMN or NCDN and Rab5 occurs in punctate structures. Arrowheads identify areas of colocalisation. Colocalisation images were generated by Volocity using automatic thresholds on non-deconvolved z -sections before excluding values below 0.05. Images (excluding the colocalisation images) are single deconvolved z -sections. Scale bars: 7 µm.

    Journal: Journal of Cell Science

    Article Title: Neurochondrin interacts with the SMN protein suggesting a novel mechanism for spinal muscular atrophy pathology

    doi: 10.1242/jcs.211482

    Figure Lengend Snippet: NCDN does not co-purify with snRNPs, while NCDN and SMN interact with Rab5 and colocalise with a subset of Rab5 vesicles within neurites of SH-SY5Y cells. (A) Incubation of whole-cell lysate from an SH-SY5Y cell line constitutively expressing NCDN–GFP with agarose beads conjugated to antibodies against the tri-methyl guanosine cap (Me3Gppp) of snRNAs (TMG beads) affinity purifies snRNPs as evidenced by the enrichment of the core snRNP protein SNRPN (detected with anti-SNRPN antibody, bottom row). The enriched snRNP fraction also contains SMN, which is essential for snRNP assembly. NCDN–GFP, however, does not co-enrich with snRNPs. Also shown is the core structure of mature snRNPs consisting of the heptameric Sm protein ring bound at the Sm-binding site of snRNA, as well as the characteristic tri-methyl guanosine Cap of snRNAs (Me 3 Gppp) at the 5′ end. (B) Affinity isolation of mRFP–Rab5 using RFP-Trap from cells co-transfected with plasmids to express mRFP–Rab5 together with NCDN–GFP, GFP–SMN or YFP alone co-enriches both NCDN–GFP (top row, detected with anti-GFP antibody, band is present in RFP-Trap lane but not Sepharose beads lane) and SMN-GFP (second row, detected with anti-GFP antibody, band is present in RFP-Trap lane but not Sepharose beads lane), but not YFP (third row, no band detected in RFP-Trap lane). Endogenous SMN (fourth row, detected with mouse anti-SMN) co-enriches with mRFP–Rab5 in all three samples. Detection of mRFP–Rab5 (bottom row, detected with anti-RFP antibody) confirms substantial enrichment of mRFP–Rab5 in all three samples. (C) Both GFP–SMN and NCDN–GFP partially colocalise with mRFP–Rab5 in a subset of mRFP–Rab5-containing vesicles in co-transfected SH-SY5Y cells (white signal in overlaid images, top row; yellow signal in colocalisation images, bottom row). (D) Enlargement of the boxed areas in C confirms that the colocalisation between SMN or NCDN and Rab5 occurs in punctate structures. Arrowheads identify areas of colocalisation. Colocalisation images were generated by Volocity using automatic thresholds on non-deconvolved z -sections before excluding values below 0.05. Images (excluding the colocalisation images) are single deconvolved z -sections. Scale bars: 7 µm.

    Article Snippet: To investigate whether the interaction between NCDN and SMN could reflect a previously unidentified role for NCDN in snRNP assembly, splicing snRNPs were affinity purified from whole-cell lysates of SH-SY5Y cells constitutively expressing NCDN–GFP using agarose beads coupled to antibodies against the characteristic tri-methyl guanosine Cap of snRNAs (TMG beads, Millipore) ( A).

    Techniques: Incubation, Expressing, Binding Assay, Isolation, Transfection, Generated